Latest Articlesddd
Eli Lilly and Company (LLY) and Incyte (INCY) announced that, after discussions with the U.S. Food …
Earlier this month, on Aug. 24, 2017, Propeller Health announced the expansion of its 2015 collaboration …
CRISPR Therapeutics (CRSP) and Massachusetts General Hospital Cancer Center (MGHCC) have entered into a two-year research collaboration and license …
When what you predicted, preached, and wished are realized, this is good news. Today’s news is …
The Week in Review #2 The Fairest Upgrades of the Week - Some analysts gave a generous …
Xoma (XOMA) stock rallied surprising many but not all. We put this firm in a special …
New Discoveries in Neurodegenerative Diseases Everyday is another day that can totally differ from the previous …
THE WEEK IN REVIEW Wall Street As we said in yesterday’s article posted under Today’s Highlights, …
About Our New Section On Sunday, August 20, 2017 we will post our first “The Week …
AFTER MANY OF THE PROHOST PICKED STOCKS NEARED REACHING THE PROHOST NEAR-TERM TARGETS, recently, external circumstances …
EXELIXIS Exelixis’ (EXEL) shareholders know well how good are the firm’s announced financial results for the …
Synopsis Most of the Prohost picked stocks gained momentum and closed higher at the end of …
Prohost Letter #412 Part 3 GLIOBLASTOMA - Is There Hope? Senator John McCain was diagnosed with a …
CELGENE Good news from Celgene (CELG) announced that the FDA approved the firm’s targeted drug Idhifa (enasidenib) for …
Prohost Letter #412 Part 2 Living Breakthroughs in The Making - Understanding the origin of diseases …
Amgen’s (AMGN) stock outperformed in the past 6 months for significant reasons and these reasons are …
It took only a few months after the dosing stages of NKTR-358 in in a Phase …
Prohost Letter #412 Part 1 Updating Our Targets - This Letter will be of three parts. …
Theravance Biopharma (TBPH) and Mylan N.V. (MYL) announced positive results from a 12-month Phase 3 safety …
Yesterday, Wednesday July 19, Vertex’s (VRTX) stock added over 20% to its value, recording a new …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
